GleamWall
中文EN

XAIR Beyond Air, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1641631 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY41.2%
TTM net income YoY9.1%
TTM EPS YoY168.8%
Revenue 3-yr CAGR201.8%
Net income 3-yr CAGR—

Margins

Gross margin10.0%
Operating margin-321.7%
Net margin-407.3%
FCF margin-259.0%
EBITDA margin-282.6%

Returns

ROE-369.6%
ROA-99.3%
ROIC (approx.)-1,404.8%
Asset turnover0.24x

Leverage & solvency

Liabilities / assets83.1%
Debt / equity0.00x
Current ratio3.67x
Interest coverage-4.95x

Cash quality & payout

Operating cash flow / net income0.59x
Accruals ratio-40.7%
Payout ratio—
Capex / revenue18.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue$2.32M$1.77M$1.91M$2.19M$1.82M$1.76M$1.15M$1.07M
Cost of revenue$2.13M$1.54M$1.81M$1.89M$2.12M$1.60M$1.18M$1.29M
Gross profit$197,000$225,000$94,000$300,000-$298,000$156,000-$32,000-$215,000
R&D expense$1.58M$1.96M$2.28M$2.43M$2.45M$3.09M$3.26M$3.00M
SG&A expense$4.59M$4.88M$4.99M$4.47M$4.91M$4.69M$3.88M$7.73M
Operating income-$5.97M-$6.61M-$7.17M-$6.60M-$7.66M-$7.62M-$7.17M-$10.95M
Interest expense$1.50M$1.49M$1.24M$1.09M$639,000$548,000$580,000$549,000
Pretax income-$8.18M-$8.15M-$10.37M-$7.63M-$8.26M-$8.08M-$8.06M-$13.33M
Net income-$7.82M-$7.93M-$10.28M-$7.34M-$7.94M-$7.69M-$8.03M-$13.03M
EBITDA-$5.17M-$5.81M-$6.37M-$5.80M-$6.86M-$6.82M-$6.37M-$10.15M
EPS (basic)-3.76-11.00—-0.85-24.98-30.67—-2.96
EPS (diluted)-3.76-11.00—-0.85-24.98-30.67—-2.96
Weighted avg. shares (diluted)2.08M721,328—8.62M317,829250,747—4.40M
Balance sheet
Cash & equivalents$5.40M$5.51M$6.74M$6.64M$9.70M$4.98M$4.67M$4.60M
Short-term investments$5.65M$4.30M$4.90M$5.02M$996,000$1.49M$2.25M$6.35M
Receivables$1.45M$1.14M$1.09M$1.15M$892,000$804,000$710,000$639,000
Inventory$1.19M$1.29M$1.41M$1.76M$2.23M$2.43M$2.42M$2.38M
Current assets$26.63M$22.85M$24.77M$25.56M$18.59M$14.99M$16.02M$19.34M
PP&E, net$7.63M$7.92M$8.25M$8.50M$9.39M$10.19M$11.01M$11.65M
Intangibles——$1.02M———$1.22M—
Total assets$36.26M$32.89M$35.38M$36.77M$30.96M$28.11M$30.06M$34.14M
Current liabilities$7.25M$6.91M$6.51M$4.99M$4.38M$4.63M$5.00M$5.43M
Long-term debt———————$11.84M
Total debt———————$11.84M
Total liabilities$30.13M$30.05M$29.18M$28.49M$17.87M$17.71M$15.72M$15.76M
Shareholders' equity$5.33M$2.00M$6.13M$8.11M$12.73M$9.93M$13.58M$17.64M
Net debt———————$7.24M
Shares outstanding1.62M743,418589,6398.40M8.01M4.69M4.13M74.33M
Cash flow statement
Operating cash flow-$5.57M-$4.95M-$4.95M-$4.22M-$4.45M-$4.53M-$6.96M-$7.73M
Capital expenditure$751,000$208,000$547,000$34,000$246,000$198,000$1.50M$537,000
Free cash flow-$6.32M-$5.15M-$5.49M-$4.25M-$4.70M-$4.72M-$8.46M-$8.27M
Investing cash flow-$2.11M$461,000-$447,000-$4.04M$240,000$576,000$2.58M-$6.94M
Financing cash flow$9.69M$3.06M$4.90M$11.21M$8.92M$4.07M$4.50M-$9.21M
Depreciation & amortization$800,000$800,000$800,000$800,000$800,000$800,000$800,000$800,000
Stock-based compensation$426,000$1.04M$427,000$1.50M$1.77M$1.58M$158,000$2.48M

Free plan shows the latest 8 periods; Pro shows all 43 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.